Since a previous study indicated that RASSF1A methylation was significantly related to poor prognosis in stage I adenocarcinoma (Tomizawa et al, 2002), we analysed our 105 cases of stage I adenocarcinoma (Table 1b). Here, RASSF1 is linked to adenocarcinoma.